Encompass Health Corporation (EHC) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 47.5% | 12.8% | 9.5% |
| 2024 | 41.6% | 16.1% | 8.5% |
| 2023 | 41.3% | 35.9% | 7.3% |
| 2022 | 40.3% | 14.5% | 6.2% |
| 2021 | 42.4% | 16.4% | 10.3% |
Download Data
Export EHC earnings history in CSV or JSON format
Free sign-in required to download data
Encompass Health Corporation (EHC) Earnings Overview
As of March 2, 2026, Encompass Health Corporation (EHC) reported trailing twelve-month net income of $541M, reflecting +0.2% year-over-year growth. The company earned $5.29 per diluted share over the past four quarters, with a net profit margin of 0.1%.
Looking at the long-term picture, EHC's 5-year EPS compound annual growth rate (CAGR) stands at +14.3%, showing solid earnings momentum. The company achieved its highest annual net income of $899M in fiscal 2010.
Encompass Health Corporation maintains positive profitability with a gross margin of 0.5%, operating margin of 0.1%, and net margin of 0.1%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including ENSG ($328M net income, 0.1% margin), BKD (-$263M net income, -0.1% margin), NHC ($101M net income, 0.1% margin), EHC has outperformed on profitability metrics. Compare EHC vs ENSG →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $566M | +24.2% | $760M | $5.55 | 9.5% | 12.8% |
| 2024 | $456M | +29.5% | $865M | $4.46 | 8.5% | 16.1% |
| 2023 | $352M | +29.9% | $1.72B | $3.47 | 7.3% | 35.9% |
| 2022 | $271M | -34.3% | $630M | $2.70 | 6.2% | 14.5% |
| 2021 | $412M | +45.0% | $659M | $4.11 | 10.3% | 16.4% |
| 2020 | $284M | -20.8% | $0 | $2.85 | 8.0% | - |
| 2019 | $359M | +22.7% | $693M | $3.61 | 7.8% | 15.0% |
| 2018 | $292M | +7.8% | $682M | $2.93 | 6.8% | 15.9% |
| 2017 | $271M | +9.5% | $649M | $2.69 | 6.9% | 16.6% |
| 2016 | $248M | +35.2% | $649M | $2.59 | 6.8% | 17.8% |
See EHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EHC Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare EHC vs AGIO
See how EHC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is EHC growing earnings?
EHC EPS of $5.29 reflects slowing growth at +0.2%, below the 5-year CAGR of +14.3%. TTM net income is $541M. Expansion rate has moderated.
What are EHC's profit margins?
Encompass Health Corporation net margin is +0.1%, with operating margin at +0.1%. Below-average margins reflect competitive or cost pressures.
How consistent are EHC's earnings?
EHC earnings data spans 1989-2025. The current earnings trend is +0.2% YoY. Historical data enables comparison across business cycles.